Infliximab Biosimilar, Anti-human TNF alpha Antibody | C011P
Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.